Lyra Therapeutics
LYRA
LYRA
44 hedge funds and large institutions have $125M invested in Lyra Therapeutics in 2023 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 7 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.83% less ownership
Funds ownership: 2.12% → 1.29% (-0.83%)
10% less capital invested
Capital invested by funds: $138M → $125M (-$13.6M)
Holders
44
Holding in Top 10
1
Calls
$965K
Puts
$6K
Top Buyers
| 1 | +$1.08M | |
| 2 | +$1.03M | |
| 3 | +$625K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$590K |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$362K |
Top Sellers
| 1 | -$9.63M | |
| 2 | -$1.48M | |
| 3 | -$1.37M | |
| 4 |
Renaissance Technologies
New York
|
-$83K |
| 5 |
BlackRock
New York
|
-$4.3K |